Cinematic rendering of 18F-DCFPyL PET/CT fusion data in a patient with metastatic clear cell renal cell carcinoma

被引：0
|
作者：
Rowe, Steven P. [1 ]
Krueger, Sebastian [2 ]
Gorin, Michael A. [3 ]
Fishman, Elliot K. [4 ]
机构：
[1] Univ N Carolina, Dept Radiol, 101 Manning Dr, Chapel Hill, NC 27514 USA
[2] Siemens Healthineers, Erlangen, Germany
[3] Icahn Sch Med Mt Sinai, Milton & Carroll Petrie Dept Urol, New York, NY USA
[4] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Sch Med, Baltimore, MD USA
来源：
BJUI COMPASS | 2024年 / 5卷 / 06期
关键词：
positron emission tomography; prostate-specific membrane antigen; PSMA;
D O I：
10.1002/bco2.324
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：548 / 550
页数：3
相关论文
共 50 条
  • [1] Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
    Alexa R. Meyer
    Michael A. Carducci
    Samuel R. Denmeade
    Mark C. Markowski
    Martin G. Pomper
    Philip M. Pierorazio
    Mohamad E. Allaf
    Steven P. Rowe
    Michael A. Gorin
    Annals of Nuclear Medicine, 2019, 33 : 617 - 623
  • [2] Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [18F]DCFPyL PET/CT
    Yin, Yafu
    Campbell, Scott P.
    Markowski, Mark C.
    Pierorazio, Philip M.
    Pomper, Martin G.
    Allaf, Mohamad E.
    Rowe, Steven P.
    Gorin, Michael A.
    MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (03) : 567 - 573
  • [3] Comparison of 18F-DCFPyL and 18F-FDG PET/computed tomography for the restaging of clear cell renal cell carcinoma: preliminary results of 15 patients
    Liu, Yachao
    Wang, Guanyun
    Yu, Hongkai
    Wu, Yue
    Lin, Mu
    Gao, Jiangping
    Xu, Baixuan
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (12) : 1299 - 1305
  • [4] Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [18F]DCFPyL PET/CT
    Yafu Yin
    Scott P. Campbell
    Mark C. Markowski
    Philip M. Pierorazio
    Martin G. Pomper
    Mohamad E. Allaf
    Steven P. Rowe
    Michael A. Gorin
    Molecular Imaging and Biology, 2019, 21 : 567 - 573
  • [5] Improved identification of patients with oligometastatic clearcell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
    Meyer, Alexa R.
    Carducci, Michael A.
    Denmeade, Samuel R.
    Markowski, Mark C.
    Pomper, Martin G.
    Pierorazio, Philip M.
    Allaf, Mohamad E.
    Rowe, Steven P.
    Gorin, Michael A.
    ANNALS OF NUCLEAR MEDICINE, 2019, 33 (08) : 617 - 623
  • [6] Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
    Jansen, Bernard H. E.
    Cysouw, Matthijs C. F.
    Vis, Andre N.
    van Moorselaar, Reindert J. A.
    Voortman, Jens
    Bodar, Yves J. L.
    Schober, Patrick R.
    Hendrikse, N. Harry
    Hoekstra, Otto S.
    Boellaard, Ronald
    Oprea-Lager, D. E.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (09) : 1320 - 1325
  • [7] Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma
    Campbell, Scott P.
    Baras, Alexander S.
    Ball, Mark W.
    Kates, Max
    Hahn, Noah M.
    Bivalacqua, Trinity J.
    Johnson, Michael H.
    Pomper, Martin G.
    Allaf, Mohamad E.
    Rowe, Steven P.
    Gorin, Michael A.
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (01) : 69 - 74
  • [8] Restaging Clear Cell Renal Carcinoma With 18F-FDG PET/CT
    Fuccio, Chiara
    Ceci, Francesco
    Castellucci, Paolo
    Spinapolice, Elena Giulia
    Palumbo, Raffaella
    D'Ambrosio, Daniela
    Bernardo, Antonio
    Brunocilla, Eugenio
    Schiavina, Riccardo
    Maffione, Anna Margherita
    Chondrogiannis, Sotirios
    Grassetto, Gaia
    Colletti, Patrick M.
    Rubello, Domenico
    Fanti, Stefano
    Trifiro, Giuseppe
    CLINICAL NUCLEAR MEDICINE, 2014, 39 (06) : E320 - E324
  • [9] 18F-DCFPyL PET/CT in primary staging of prostate cancer
    Wondergem M.
    van der Zant F.M.
    Roeleveld T.A.
    Srbljin S.
    Kartachova M.S.
    van Dongen A.
    Franken V.
    Knol R.J.J.
    European Journal of Hybrid Imaging, 2 (1):
  • [10] Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma
    Scott P. Campbell
    Alexander S. Baras
    Mark W. Ball
    Max Kates
    Noah M. Hahn
    Trinity J. Bivalacqua
    Michael H. Johnson
    Martin G. Pomper
    Mohamad E. Allaf
    Steven P. Rowe
    Michael A. Gorin
    Annals of Nuclear Medicine, 2018, 32 : 69 - 74
12345